Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc.
Avacta Life Sciences Ltd
Boehringer Ingelheim
Pfizer
Seagen Inc.
AstraZeneca
Kivu Bioscience Inc.
BeOne Medicines
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Eli Lilly and Company
Debiopharm International SA
Novartis
Boehringer Ingelheim
NiKang Therapeutics, Inc.
MacroGenics
Amgen
SystImmune Inc.
SN BioScience
Boundless Bio, Inc.
Boehringer Ingelheim
SciTech Development, Inc.
AbbVie
Amgen
Amgen
Nerviano Medical Sciences
Boehringer Ingelheim
AbbVie
Incyte Corporation
Janux Therapeutics
Novartis
Amgen
Sichuan Baili Pharmaceutical Co., Ltd.
NiKang Therapeutics, Inc.
Novelty Nobility, Inc.
Hangzhou DAC Biotechnology Co., Ltd.
Sichuan Baili Pharmaceutical Co., Ltd.
Bristol-Myers Squibb
Pfizer
Hoffmann-La Roche
Advenchen Laboratories, LLC
Biotroy Therapeutics
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Incyte Corporation
Chipscreen Biosciences, Ltd.
CSPC Megalith Biopharmaceutical Co.,Ltd.
Hansoh BioMedical R&D Company
Theratechnologies
Hoffmann-La Roche
Janssen Research & Development, LLC